Hepion Pharmaceuticals Inc HEPA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/05/22 EDT
0.60quote price arrow down-0.03 (-4.54%)
Volume
3,685
Close
0.6286quote price arrow up+0.0686 (+12.26%)
Volume
228,640
52 week range
0.49 - 1.85
Loading...
  • Open0.5472
  • Day High0.6439
  • Day Low0.5418
  • Prev Close0.56
  • 52 Week High1.85
  • 52 Week High Date09/08/21
  • 52 Week Low0.49
  • 52 Week Low Date08/01/22

Key Stats

  • Market Cap47.92M
  • Shares Out76.23M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-44.86

KEY STATS

  • Open0.5472
  • Day High0.6439
  • Day Low0.5418
  • Prev Close0.56
  • 52 Week High1.85
  • 52 Week High Date09/08/21
  • 52 Week Low0.49
  • 52 Week Low Date08/01/22
  • Market Cap47.92M
  • Shares Out76.23M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-44.86

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-1.43
  • Fwd P/E (NTM)-1.12
  • EBITDA (TTM)-31.534M
  • ROE (TTM)-33.45%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/16/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hepion Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development of drug therapy for treatment of chronic liver diseases. This therapeutic approach targets fibrosis, inflammation, and the treatment hepatocellular carcinoma (HCC) associated with non-alcoholic steatohepatitis (NASH), viral hepatitis and other liver diseases. The Company's cyclophilin inhibitor, Rencofilstat (formerly CRV431), is developed to offer benefits to address...
Gary Jacob Ph.D.
Independent Chairman of the Board
Robert Foster Ph.D.
Chief Executive Officer, Chief Scientific Officer, Director
John Cavan
Chief Financial Officer
Address
399 Thornall St
Edison, NJ
08837-2236
United States

Top Peers

SYMBOLLASTCHG%CHG
CRVS
Corvus Pharmaceuticals Inc
0.916+0.016+1.78%
ELDN
Eledon Pharmaceuticals Inc
3.17+0.17+5.67%
GLTO
Galecto Inc
2.09+0.18+9.42%
OTLC
Oncotelic Therapeutics Inc
0.0987-0.0013-1.30%
OGEN
Oragenics Inc
0.37-0.012-3.1414%